Lataa...
Molecular Heterogeneity of Triple Negative Breast Cancer
Triple-negative breast cancers (TNBCs) are known to be an aggressive group of breast cancers with higher rates of relapse stage for stage compared to ER/PR positive and HER2 positive breast cancers despite optimal loco-regional and systemic therapies. To date, not a single targeted therapy has been...
Tallennettuna:
| Julkaisussa: | Curr Breast Cancer Rep |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4235783/ https://ncbi.nlm.nih.gov/pubmed/25419441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-014-0152-1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|